Loading…
Loading…
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli
Aardvark Therapeutics, Inc. (AARD) Investors with Substantial Losses Have Opportunity to Lead Aardvark Class Action Lawsuit Before October 13 De
Aardvark Therapeutics (AARD) Investors: Securities Fraud Class Action Filed, Contact Hagens Berman Before October 13, 2026 Lead Plaintiff Deadli
Law Offices of Howard G. Smith reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the case filed on behalf of invest
[url="]Glancy Prongay Wolke and Rotter LLP[/url] reminds investors of the upcoming October 13, 2026 deadline to file a lead plaintiff motion in the class action f
[url="]The Law Offices of Frank R. Cruz[/url] reminds investors of the upcoming October 13, 2026 deadline to participate as a lead plaintiff in the securities f
[url="]Faruqi and Faruqi, LLP[/url], a leading national securities law firm, is investigating potential claims against Aardvark Therapeutics, Inc. (âAardvarkâ
Viridian Therapeutics, Inc. (Nasdaq: VRDN), a biotechnology company focused on discovering, developing, and commercializing potentially best-in-class medicines
SEC filings for IND aren't indexed yet — common for recently launched funds. Browse the issuer's filings on SEC EDGAR directly.